This study by the French Vasculitis Study Group 1 is not the first setback for methotrexate in the treatment of ANCA-associated vasculitis. A randomized, controlled trial of induction therapy in ...
Although immunosuppressive treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis results in a 10-year survival rate of 60–90%, a substantial number of patients suffer ...
Avacopan treatment for vasculitis patients shows a significant risk of liver injury, especially in older and low-weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback